Vapogenix's Unattributed VC Round

Vapogenix raised a round of funding on January 11, 2018. Investors include Pamoja Capital.

Vapogenix is an early stage company focused on developing novel, non-opioid analgesics for acute and chronic pain management. Vapogenix's licensed technology covers novel formulations of known medicat…

Articles about Vapogenix's Unattributed VC Round: